"10.1371_journal.pone.0101768","plos one","2014-07-08T00:00:00Z","Antonio Gonz√°lez-P√©rez; Mar√≠a E S√°ez; Saga Johansson; P√©ter Nagy; Luis A Garc√≠a Rodr√≠guez","The Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain; Andalusian Bioinformatics Research Centre (CAEBi), Seville, Spain; AstraZeneca R&D, M√∂lndal, Sweden","Conceived and designed the experiments: AGP MES SJ PN LAGR. Performed the experiments: AGP LAGR MES. Analyzed the data: AGP MES SJ PN LAGR. Wrote the paper: AGP MES SJ PN LAGR.","Antonio Gonz√°lez-P√©rez, Luis A. Garc√≠a Rodr√≠guez, and Mar√≠a Eugenia S√°ez work for CEIFE, which has received research funding from AstraZeneca R&D, M√∂lndal, Sweden and Bayer Pharma AG, Berlin, Germany. Luis A. Garc√≠a Rodr√≠guez has received honoraria for serving on scientific advisory boards for AstraZeneca and Bayer. Saga Johansson and P√©ter Nagy are employees of AstraZeneca R&D, M√∂lndal, Sweden. Medical writing services from Carolyn Brechin PhD and Stephen Sweet PhD of Oxford PharmaGenesis Ltd, Oxford, UK, were funded by AstraZeneca. The declared potential competing interests do not alter the authors‚Äô adherence to PLOS ONE policies on sharing data and materials.","2014","07","Antonio Gonz√°lez-P√©rez","AG√P√",5,TRUE,5,3,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
